Anti-IgLON5 Disease – The Current State of Knowledge and Further Perspectives

Anti-IgLON5 disease is a relatively new neurological entity with the first cases reported in 2014. So far, less than 70 articles on this topic have been published. Due to its unspecific symptomatology, diverse progression, novelty and ambiguous character, it remains a difficulty for both clinical pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Madetko, Natalia, Marzec, Weronika, Kowalska, Agata, Przewodowska, Dominika, Alster, Piotr, Koziorowski, Dariusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921982/
https://www.ncbi.nlm.nih.gov/pubmed/35300333
http://dx.doi.org/10.3389/fimmu.2022.852215
_version_ 1784669431763304448
author Madetko, Natalia
Marzec, Weronika
Kowalska, Agata
Przewodowska, Dominika
Alster, Piotr
Koziorowski, Dariusz
author_facet Madetko, Natalia
Marzec, Weronika
Kowalska, Agata
Przewodowska, Dominika
Alster, Piotr
Koziorowski, Dariusz
author_sort Madetko, Natalia
collection PubMed
description Anti-IgLON5 disease is a relatively new neurological entity with the first cases reported in 2014. So far, less than 70 articles on this topic have been published. Due to its unspecific symptomatology, diverse progression, novelty and ambiguous character, it remains a difficulty for both clinical practitioners and scientists. The aim of this review is to summarize the current knowledge concerning anti-IgLON5 disease; mechanisms underlying its cause, symptomatology, clinical progression, differential diagnosis and treatment, which could be helpful in clinical practice and future research.
format Online
Article
Text
id pubmed-8921982
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89219822022-03-16 Anti-IgLON5 Disease – The Current State of Knowledge and Further Perspectives Madetko, Natalia Marzec, Weronika Kowalska, Agata Przewodowska, Dominika Alster, Piotr Koziorowski, Dariusz Front Immunol Immunology Anti-IgLON5 disease is a relatively new neurological entity with the first cases reported in 2014. So far, less than 70 articles on this topic have been published. Due to its unspecific symptomatology, diverse progression, novelty and ambiguous character, it remains a difficulty for both clinical practitioners and scientists. The aim of this review is to summarize the current knowledge concerning anti-IgLON5 disease; mechanisms underlying its cause, symptomatology, clinical progression, differential diagnosis and treatment, which could be helpful in clinical practice and future research. Frontiers Media S.A. 2022-03-01 /pmc/articles/PMC8921982/ /pubmed/35300333 http://dx.doi.org/10.3389/fimmu.2022.852215 Text en Copyright © 2022 Madetko, Marzec, Kowalska, Przewodowska, Alster and Koziorowski https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Madetko, Natalia
Marzec, Weronika
Kowalska, Agata
Przewodowska, Dominika
Alster, Piotr
Koziorowski, Dariusz
Anti-IgLON5 Disease – The Current State of Knowledge and Further Perspectives
title Anti-IgLON5 Disease – The Current State of Knowledge and Further Perspectives
title_full Anti-IgLON5 Disease – The Current State of Knowledge and Further Perspectives
title_fullStr Anti-IgLON5 Disease – The Current State of Knowledge and Further Perspectives
title_full_unstemmed Anti-IgLON5 Disease – The Current State of Knowledge and Further Perspectives
title_short Anti-IgLON5 Disease – The Current State of Knowledge and Further Perspectives
title_sort anti-iglon5 disease – the current state of knowledge and further perspectives
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921982/
https://www.ncbi.nlm.nih.gov/pubmed/35300333
http://dx.doi.org/10.3389/fimmu.2022.852215
work_keys_str_mv AT madetkonatalia antiiglon5diseasethecurrentstateofknowledgeandfurtherperspectives
AT marzecweronika antiiglon5diseasethecurrentstateofknowledgeandfurtherperspectives
AT kowalskaagata antiiglon5diseasethecurrentstateofknowledgeandfurtherperspectives
AT przewodowskadominika antiiglon5diseasethecurrentstateofknowledgeandfurtherperspectives
AT alsterpiotr antiiglon5diseasethecurrentstateofknowledgeandfurtherperspectives
AT koziorowskidariusz antiiglon5diseasethecurrentstateofknowledgeandfurtherperspectives

Ejemplares similares